Neuropeptides: Modulators of immune responses in health and disease

International Review of Neurobiology

Volumn 52, Issue , 2002, Pages 67-91

  Jessop, David S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROPEPTIDE;

ANIMAL; AUTOIMMUNE DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; PHYSIOLOGY; REVIEW; STRESS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE SYSTEM; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; STRESS;

EID: 0036356060     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(02)52006-7     Document Type: Review

References (142)

1. Aguila, M. C, Rodriguez, A. M., Aguila-Mansilla, H. N., and Lee, W. T. (1996). Somatostatin antisense oligodeoxynuclcotide-mediated stimulation oflymphocyte proliferation in culture. Endocrinology 137, 1585-1590.
2. Aird, F., Clevenger, C. V., Prystowsky, M. B., and Redei, E. (1993). Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc. Natl. Acad. Sci. USA 90, 7104-7108.
3. Azuma, Y, Wang, P. L., Shinohara, M., and Ohura, K. (2000). Immunomodulation of the neutrophil respiratory burst by endomorphins 1 and 2. Immunol. Lett. 75, 55-59.
4. Baigent, S. M. (2001). Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22, 809-820.
5. Bhardwaj, R., Bccher,E., Mahnke, K., Harlmeyer, M., Schwarz, T., Scholzcn, T., and Luger, T. A. (1997). Evidence for the differential expression of the functional α-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol. 158, 3378-3384.
6. Bhardwaj, R. S., Schwarz, A., Becher, E., Mahnke, K., Aragane, Y, Schwarz, X, and Luger, T. A. (1996). Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol. 156, 2517-2521.
7. Blalock, J. E. (1994). The syntax of immunc-neuroendocrine communication. Immunol. Today 15, 504-511.
8. Blalock, J. E. (1999). Proopiomelanocortin and the immune-neuroendocrine connection. Ann. N.Y. Acad. Sci. 885, 161-172.
9. Blum, A. M., Elliott, D. E., Metwali, A., Li, J., Qadir, K. and Weinstock, J. V. (1998). Substance P regulates somatostatin expression in inflammation. J. Immunol. 161, 6316-6322.
10. Boehme, S. A., Gaur, A., Crowe, P. D. Liu, X. J., Wong, T. Pahuja, A., Ling, N., Vale, W. De Souza, E. B., and Conlon, P. J. (1997). Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy. Cell Immunol. 176, 103-112.
11. Bracci-Laudiero, L., Aloe, L., Stenfors, C, Theodorsson, E., and Lundeberg, T. (1998). Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs. Neurosci. Lett. 248, 97-100.
12. Brouxhon, S. M., Prasad, A. V., Joseph, S. A., Kelten, D. L., and Bellinger, D. (1998). Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav. Immun. 12, 107-122.
13. Buzzetti, R., McLoughlin, L., Lavender, P., Clark, A., and Rees, L. H. (1989). Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormonelike im-munoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J. Clin. Invest. 83, 733-737.
14. Cabot, P. J., Carter, L., Gaiddon, C, Zhang, Q. Schaler, M., Loeffler, J. P., and Stein, C. (1997). Immune cell-derived β-endorphin. Production, release, and control of inflammatory pain in rats. J. Clin. Invest. 100, 142-148.
15. Campbell, R. M., and Scanes, C. G. (1995). Endocrine hormones "moonlighting" as immune modulators: Roles for somatostatin and GH-relcasing factor. J. Endocrinol. 147, 383-396.
16. Carrigan, K. A., Nelson, O. J., and Lysle, D. T. (2000). Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology (Berlin) 151, 299-305.
17. Chancellor-Freeland. C, Zhu, G. F., Kage, R., Beller, D. I., Leeman, S. E., and Black, P. H. (1995). Substance P and stress-induced changes in macrophages. Ann. N. Y Acad. Sci. 771, 472-484.
18. Chikanza, I. C, and Grossman, A. B. (1998). Hypothalamic-pituitary-mediated immunomodulaiion: Arginine vasopressin is a neuroendocrine immune mediator. Br. J. Rheumatol. 37, 131-136.
19. Chowdrey, H. S., Lightman, S. L., Harbuz, M. S., Larsen, P. J., and Jessop, D. S. (1994). Contents of corticotropin-releasing hormone and arginine vasopressin immunoreartivity in the spleen and thymus during a chronic inflammatory stress. J. Neuroimmunol. 53, 17-21.
20. Clarke, B. I., and Bost, K. L. (1989). Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes. J. Immunol. 143, 464-469.
21. Clark, R. (1997). The somatogenic hormones and insulin-like growth factor-1: Stimulators of lymphopoiesis and immune function. Endoer. Rev. 18, 157-179.
22. Clevenger. C. V., Freier, D. O., and Kline, J. B. (1998). Prolactin receptor signal transduction in cells of the immune svstem. J. Endocrinol. 157, 187-197.
23. Conti, F., Pittoni, V, Sacerdote, P., Priori, R., Moroni, P. L., and Valesini, G. (1998). Decreased immunoreactivc β-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin. Exp. Rheumatol. 16, 729-732.
24. Coventry, T. L., Jessop, D. S., Finn, D. P., Crabb, M. D., Kinoshita, H., and Harbuz, M. S. (2001). Endomorphins and activation of the hvpothalamo-pituitary-adrenal axis. J. Endocrinol. 169, 185-193.
25. Crofford, L.J., Sano, H., Karalis, K., Webster, E., Goldmuntz, E., Chrousos, G., and Wilder, R. (1992). Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin, invest. 90, 2555-2564.
26. Crofford, L. J., Sano, H., Karalis, K., Friedman, T. C, Epps, II. R., Remmers, E. P., Mathern, P., Chrousos, G. P., and Wilder, R. L. (1993). Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151, 1587-1596.
27. De Giorgio, R., Tazzari, P. L., Barbara, G., Stanghellini, V., and Corinaldesi, R. (1998). Detection of substance P immunoreactivity in human peripheral leukocytes. J. Neuroimmunol. 82, 175-181.
28. Delgado, M., and Ganca, D. (1999). Vasoactive intestinal peptide and pituitary adenylate cvclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Els activation. J. Biol. Chem. 274, 31930-31940.
29. Delgado, M., Martinez, C. Leceta, J., Garrido, F., and Gomariz, R. P. (1996). Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets. Peptides 17, 803-807.
30. Delgado M., Abad C., Martinez C., Leceta J., and Gomariz R.P. (2001 ). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563-568.
31. Elands, J., Van Woudenberg, A., Resink, A., and de Kloet, R. (1990). Vasopressin receptor capacity of human blood peripheral mononuclear cells is sex dependent. Brain Behav. Immun. 4, 30-38.
32. Elenkov, I. J. and Chrousos, G. P. (1999). Stress, cytokine patterns and susceptibility to disease. Baillieres Best Pract. Res. Clin. Endocrinol. Metah. 13, 583-595.
33. Elliott, D. E., Blum, A. M., Li, J., Metwali, A., and Weinstock, J. V. (1998). Preprosomatostatin messenger RNA is expressed by inflammatory cells and induced by inflammatory mediators and cytokines. J. Immunol. 160, 3997-4003.
34. Fclten, D. I., Felten, S. V, Bellinger. S. I., Carlson, S. L., Ackerman. K. S., Madden, J. A., Olschowka, J. A., and Livnat, S. (1987). Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol. Rev. 100, 225-260.
35. Fuchs, B. A., and Pructt, S. B. (1993). Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther 266, 417-423.
36. Fulford, A. J., Harbuz, M. S., and Jessop, D. S. (2000). Antisense inhibition of proopiomelanocortin and proenkephalin A messenger RNA translation alters rat immune cell function in vitro. J. Neuroimmunol. 106, 6-13.
37. Gaillard, R. C, Daneva, X, Hadid, R., Muller, K., and Spinedi, E. (1998). The hypothalamo-pituitary-adrenal axis of athymic Swiss nude mice. The implications of X lymphocytes in the ACTH release from immune cells. Ann. N. Y. Acad. Sci. 840, 480-490.
38. Galin.F. S., LeBoeuf, R. D., and Blalock, J. E. (1991). Corticotropin-releasing factor upregulales expression of two truncated proopiomelanocortin transcripts in murine lymphocytes. J. Neuroimmunol. 31, 51-58.
39. Gaytan, F., Martinez-Fuentes, A. J., Garcia-Navarro, F., Vaudry, H., and Aguilar, E. (1994). Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res. 276, 223-227.
40. Getting, S. J., Gibbs, L., Clark, A. J., Flower, R. J., and Perretti, M. (1999). POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J. Immunol. 162, 7446-7453.
41. Getting, S. J., Allcock, G. H., Flower, R., and Perretti, M. (2001). Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69, 98-104.
42. Goetzl, E. J., Pankhaniya, R. R., Gaufo, G., Mu, Y, Xia, M., and Sreedharan, S. P. (1998). Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann. N. Y. Acad. Sci. 840, 540-550.
43. Groneberg, D. A., and Fischer, A. (2001). Endogenous opioids as mediators of asthma. Pulm. Pharmacol. Ther. 14, 383-389.
44. Harbuz, M. S., Chowdrey, H. S., Lightman, S. L., Wei, E. X, and Jessop, D. S. (1996). An investigation into the effects of chronic infusion of corticotrophin-releasing factor on hind paw inflammation in adjuvant-induced arthritis. Stress 1, 105-111.
45. Harbuz, M. S., Chover-Gonzalez, A., Gibert-Rahola, J., and Jessop, D. S. (2002). Protective effect of prior acute immune challenge, but not footshock, on inflammation in the rat. Brain. Behav. Immun. 16, 439-449.
46. Hargreaves, K. M., Costello, A. H., and Joris, J. L. (1989). Release from inflamed tissue of a substance with properties similar to corticotropin-releasing factor. Neuroendocrinology 49, 476-482.
47. Hashemi, F. B., Hughes, X. K., and Smith, E. M. (1998). Human immunodeficiency virus induction of corticotropin in lymphoid cells. J. Clin. Endocrinol. Metab. 83, 4373-4381.
48. Hassan, A. H., Przewlocki, R., Herz, A., and Stein, C. (1992). Dynorphin, a preferential ligand for k-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosa. Lett. 140, 85-88.
49. Heijnen, C. J., Zijlstra, J., Kavelaars, A., Croiset, G., and Ballieux, R. E. (1987). Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav. Immun. 1, 284-291.
50. Ientile, R., Ginoprelli, X, Cannavo, G., Picerno, I., and Piedimonte, G. (1997). Effect of β-endorphin on cell growth and cell death in human peripheral blood lymphocytes. J. Neuroimmunol. 80, 87-92.
51. Jessop, D. S. (1998). Neuropeptides: Modulators of the immune system. Cuir. Opin. Endocrinol. Diabetes 5, 52-58.
52. Jessop, D. S. (1999). Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J. Endocrinol. 160, 169-180.
53. Jessop, D. S. (2001). Neuropeptides in the immune system: Functional roles in health and disease. In "Frontiers of Hormone Research" (R. Gaillard, ed.), Vol. 29, pp. 50-68. S. Karger AG, Basel.
54. Jessop, D. S., Lightman, S. L., and Chowdrey, H. S. (1994). Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus. J. Neuroimmunol. 49, 197-203.
55. Jessop, D. S., Renshaw, D., Lightman, S. L., and Harbuz, M. S. (1995a). Changes in ACTH and β-endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin. J. Neuroimmunol. 60, 29-35.
56. Jessop, D. S., Chowdrey, H. S., Lightman, S. L., and Larsen, P. J. (1995b). Vasopressin is located within lymphocytes in the rat spleen. J. Neuroimmunol. 56, 219-223.
57. Jessop, D. S., Harbuz, M. S., Snelson, C. L., Dayan, C. M., and Lightman, S. L. (1997a). An anti-sense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro. J. Neuroimmunol. 75, 135-140.
58. Jessop, D. S., Douthwaite, J. D., Conde, G. L., Lightman, S. L., Dayan, C. M., and Harbuz, M. S. (1997b). Effects of acute stress or centrally injected interleukin-1β on neuropeptide expression in the immune system. Stress 2, 133-144.
59. Jessop, D. S., Major, G. N., Coventry, T. L., Kaye, S. J., Fulford, A. J., Harbuz, M. S., and de Bree, F. M. (2000). Opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J. Neuroimmunol. 106, 53-59.
60. Jessop, D. S., Harbuz, M. S., and Lightman, S. L. (2001). CRH in chronic inflammatory stress. Peptides 22, 803-807.
61. Jessop, D. S., Richards, L. J., and Harbuz, M. S. (2002). Opioid peptides endomorphin (EM)-l and EM-2 in the immune system in a rodent model of inflammation. Ann. N.Y. Acad. Sci. 966, 456-463.
62. Johnson, E. W., Hughes, T. K. Jr, and Smith, E. M. (2001). ACTH receptor distribution and modulation among murine mononuclear leukocyte populations. J. Biol. Regul. Homeost. Agents 15, 156-162.
63. Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature (London) 399, 697-700.
64. Kageyama, K., Bradbury, M. J., Zhao, L., Blount, A. L., and Vale, W. W. (1999). Urocortin messenger ribonucleic acid: Tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140, 5651-5658.
65. Kamphuis, S., Kavelaars, A., Brooimans, R., Kuis, W., Zegers, B. J. M., and Heijnen, C. J. (1997). T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J. Neuroimmunol. 79, 91-99.
66. Kamphuis, S., Eriksson, E, Kavelaars, A., Zijlstra, J., van de Pol, M., Kuis, W., and Heijnen, C. J. (1998). Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production. J. Neuroimmunol. 84, 53-60.
67. Karalis, K., Sano, H., Redwine, J., Listwak, J., Wilder, R., and Chrousos, G. (1991). Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254, 421-423.
68. Karalis, K., Mastorakos, G., Chrousos, G. P., and Tolis, G. (1994). Somatostatin analogues suppress the inflammatory reaction in vivo. J. Clin. Invest. 93, 2000-2006.
69. Karalis, K, Muglia, I.J., Bae, D., Hilderbrand, H., and Majzoud, J. A. (1997). CRH and the immune system. J. Neuroimmunol. 72, 131-136.
70. Kavelaars, A., Ballieux, R. E., and Heijnen, C. J. (1989). The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells. J. Immunol. 142, 2338-2342.
71. Kavelaars, A., Ballieux, R. E., and Heijnen, C. J. (1990). In vitro β-adrenergic stimulation of lymphocytes induces the release of immunoreactive β-endorphin. Endocrinology 126, 3028-3032.
72. Khachatryan, A., Guerder, S., Palluault, F., Cote, G., Solimena, M., Valentijn, K., Millet, I., Flavell, R. A., and Vignery, S. (1997). Targeted expression of the neuropeptide calcitonin gene-related peptide to β cells prevents diabetes in NOD mice. J. Immunol. 158, 1409-1416.
73. Khalil, Z., Sanderson, K., Modig, M., and Nyberg, F. (1999). Modulation of peripheral inflammation by locally administered endomorphin-1. Inflamm. Res. 48, 550-556.
74. Kohno, M., Kawahito, V, Tsubouchi, Y, Ilashiramolo, A., Yamada, R., Inoue, K. I., Kusaka, Y, Kubo, T, Elenkov, I. J., Chrousos, G. P., Kondo, M., and Sano, H. (2001). Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: Relation to inflammatory activity. J. Clin. Endocrinol. Metab. 86, 4344-4352.
75. Kong, I.Y., McMillian, M. K., Hudson, P. M., Jin, L., and Hong, J. S. (1997). Inhibition of lipopolysaecharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J. Pharmacol. Exp. Ther. 280, 61-66.
76. Kraus, J., Borner, C, Giannini, E., Hickfang, K., Braun, H., Mayer, P., Hoehe, M. R., Ambrosch, A., Konig, W., and Hollt, V. (2001). Regulation of µ-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 276, 43901-43908.
77. Levine, J. D., Fields, H. I., and Basbaum, A. I. (1993). Peptides and the primary afferent nociceptor. J. Neurosci. 13, 2273-2286.
78. Linner, K. M., Quist, H. E., and Sharp. B. M. (1995). Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. Immunol. 154, 5049-5060.
79. Lipton, J. M., and Catania, A. (1998). Mechanisms of anti-inflammatory action of the neuro immunomodulatory peptide α-MSH. Ann. N. Y. Acad. Sci. 840, 373-380.
80. Lolait, S., Clements, J. A., Markwick, A., Cheng, G, McNulty, M., Smith, A. I., and Funder, J. W. (1986). Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of β-endorphin in spleen macrophages. J. Clin. Invest. 77, 1776-1779.
81. Lyons, P. D., and Blalock, J. E. (1995). The kinetics of ACTH expression in rat leukocyte subpopulations. J. Neuroimmunol. 63, 103-112.
82. Lyons, P. D., and Blalock, J. E. (1997). Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 78, 47-56.
83. Machelska, H., Cabot, P. J., Mousa, S. A., Zhang, Q., and Stein, C. (1998). Pain control in inflammation governed by selectins. Nat. Med. 4, 1425-1428.
84. Madden, J. J., Whaley, W. L., Ketelsen, D., and Donahoe, R. M. (2001). The morphine-binding site on human activated T-cells is not related to the µ-opioid receptor. Drug Alcohol Depend. 62, 131-139.
85. Martens, H., Goxe, B., and Geenen, V. (1996). The thymic repertoire of neuroendocrine self-antigens: Physiological implications in T-cell life and death. Immunol. Today 17, 312-317.
86. McCain, H. W., Lamster, I. B., Bozzonc, J. M., and Grbic, J. T. (1982). β-Endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci. 31, 1619-1624.
87. McEvoy, A. N., Bresnihan, B., FitzGerald, O., and Murphy, E. P. (2001). Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 a-corticotropin-relcasing hormone receptor. Arthritis Rheum. 44, 1761-1767.
88. Millet, I., Phillips, R. J., Sherwin, R. S., Ghosh, S., Voll, R. E., Flavell, R. A., Vignery, A., and Rincon, M. (2000). Inhibition of NF-κB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J. Biol. Chem. 275, 15114-15121.
89. Mousa, S. A., Schafer, M., Mitchell, W. M., Hassan, A. H., and Stein, C. (1996). Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 311, 221-231.
90. Murphy, E. P., McEvoy, A., Conneely, O. M., Bresnihan, B., and FitzGerald, O. (2001). Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum. 44, 782-793.
91. Ni, X., Lin, B. C, Song, C. Y, and Wang, C. H. (1999). Dynorphin A enhances mitogen-induced proliferative response and inlerleukin-2 production of rat splenocytes. Neuropeptides 33, 137-143.
92. Nishioka, T, Kurokawa, H., Takao, T, Kumon, Y, Nishiya, K., and Hashimoto, K. (1996). Differential changes of corticotropin releasing hormone (CRH) concentrations in plasma and synovial fluids of patients with rheumatoid arthritis (RA). En doer. J. 43, 241-247.
93. Ohsawa, M., Mizoguchi, H., Narita, M., Nagase, H., Kampine, J. P., and Tseng, L. F. (2001). Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 298, 592-597.
94. Owen, D. L., Morley, J. S., Ensor, D. M., and Miles, J. B. (1998). The C-terminal tetrapeptide of β-endorphin (MPF) enhances lymphocyte proliferative responses. Neuropeptides 32, 131-139.
95. Pampusch, M. S., Serie, J. R., Osinski, M. A., Seybold, V. S., Murtaugh, M. P., and Brown, D. R. (2000). Expression of nociceptin/OFQreceptor and prepro-nociceptin/OFQin lymphoid tissues. Peplidest 21, 1865-1870.
96. Panerai, A. E., and Sacerdole, P. (1997). β-endorphin in the immune system: A role at last? Immunol. Today 18, 317-319.
97. Panerai, A. E., Sacerdote, P., Bianchi, M., and Manfredi, B. (1997). Intermittent but not continuous inescapable footshock stress and intracerebroventricular intcrleukin-1 similarly affect immune responses and immunocyte β-endorphin concentrations in the rat. Int. J. Clin. Pharmacol. Res. 17, 115-126.
98. Park, J. H., Lee, Y. J., Na, S. Y, and Kim, K. L. (2000). Oenomic organization and tissue-specific expression of rat urocortin. Neurosci. Lett. 292, 45-48.
99. Pasnik, J., Tchorzewski, H., Baj, Z., Luciak, M., and Tchorzewski, M. (1999). Priming effect of Met-enkephalin and β-endorphin on chemiluminescence, chemotaxis and CD11b molecule expression on human neutrophils in vitro. Immunol. Lett. 67, 77-83.
100. Peluso, J., LaForge, K. S., Matthes, H. W., Kreek, M. J., Kieffer, B. I., and Gaveriaux-Ruff, C. (1998). Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J. Neuroimmunol, 81, 184-192.
101. Peluso, J., Gaveriaux-Ruff, C, Matthes, H. W., Filliol, D., and Kieffer, B. L. (2001). Orphanin FQ/nociceptin binds to f unctionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation. Brain Res. Bull. 54, 655-660.
102. Poliak, S., Mor, F., Conlon, P., Wong, T, Ling, N., Rivier, J., Vale, W., and Steinman, L. (1997). Stress and autoimmunity: The neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158, 5751-5756.
103. Postel-Vinay, M. C, de Mello-Coelho, V, Gagnerault, M. C, and Dardenne, M. (1997). Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology: 138, 1816-1820.
104. Przewlocki, R., Hassan, A. II. S., Lason, W., Epplen, C, Herz, A., and Stein, C. (1992). Gene expression and localisation of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception. Neuroscience 48, 491-500.
105. Raap, T, Justen, II P., Miller, I. E., Cutolo, M., Scholmerich, J., and Straub, R. H. (2000). Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis. J. Rheumatol. 27, 2558-2565.
106. Radulovic, M., Dautzenberg, F. M., Sydow, S., Radulovic, J., and Spiess, J. (1999). Corticotropin-releasing factor receptor 1 in mouse spleen: Expression after immune stimulation and identification of receptor-bearing cells. J. Immunol. 162, 3013-3021.
107. Rittner, H. L., Brack, A., Machelska, H., Mousa, S. A., Bauer, M., Schafer, M., and Stein, C. (2001). Opioid peptide-expressing leukocytes: Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95, 500-508.
108. Roy, S., Ge, B. L., Ramakrishnan, S., Lee, N. M., and Loh, H. H. (1991). [3H] morphine binding is enhanced by IL-1-stimulated thymocyte proliferation. FEES Lett. 287, 93-96.
109. Sacerdote, P., Di San Secondo,V. E., Sirchia, G., Manfredi, B., and Panerai, A. E. (1998). Endogenous opioids modulate allograft rejection time in mice: Possible relation with Th1/Th2 cytokines. Clin. Exp. Immunol. 113, 465-469.
110. Sacerdote, P., Gaspani, L., and Panerai, A. E. (2000). The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in normal and skin-grafted mice. Ann. N.Y. Acad. Set. 917, 755-763.
111. Said, S. I., and Dickman, K. G. (2000). Pathways of inflammation and cell death in the lung: Modulation by vasoactive intestinal peptide. Regul. Pept. 93, 21-29.
112. Sakane, T, and Suzuki, N. (1998). The role of somatostatin in the pathophysiology of rheumatoid arthritis. Clin. Exp. Rheumatol. 16, 745-749.
113. Sakurada, S., Hayashi, T, Yuhki, M., Orito, T, Zadina, J. E., Kastin, A. J., Fujimura, X, Murayama, K., Sakurada, C, Sakurada, X, Narita, M., Suzuki, X, Xan-no, K., and Xseng, L. F. (2001). Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur. J. Pharmacol. 427, 203-210.
114. Savino, W., De Mello-Coelho, V, and Dardennc, M. (1995). Control of the thymic micro-environment by growth hormone/insulin-like growth factor-l-mediated circuits. Neuroim-munomodulation 2, 313-318.
115. Schafer, M., Mousa, S. A., and Stein, C. (1997). Corticotropin-releasing factor in antinocicep-tion and inflammation. Eur. J. Pharmacol. 323, 1-10.
116. Serhan, C. N., Fierro, I. M., Chiang, N., and Pouliot, M. (2001). Nociceptin stimulates neutrophil chemotaxis and recruitment: Inhibition by aspirin-triggered-15-epi-lipoxin A4. J. Immunol. 166, 3650-3654.
117. Shahabi, N. A., Linner, K. M., and Sharp, B. M. (1990). Murine splenocytes express a naloxone-insensitive binding site for β-endorphin. Endoainology 126, 1442-1448.
118. Sharp, B. M., Roy, S., and Bidlack, J. M. (1998). Evidence for opioid receptors on cells involved in host response and the immune system. J. Neuroimmunol. 83, 45-56.
119. Skofitsch, G., Hamill, G. S., and Jacobowitz, D. M. (1984). Capsaicin depletes corticotropin-releasing factor-like immunoreactive neurons in the rat spinal cord and medulla oblongata. Neuroendocrinology 38, 514-517.
120. Singh, V. (1989). Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interletikin-2 receptor expression. J. Neuroimmunol. 23, 256-262.
121. Singh, V., and Leu, C. (1990). Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci. Lett. 120, 151-154.
122. Smith, E. M., Morrill, A. C, Meyer, W. J., and Blalock, J. E. (1986). Corticotropin releasing factor induction of leukocyte derived immunoreactive ACXH and endorphins. Nature (London) 321, 881.
123. Smith, E. M., Brosnan, P., Meyer, W. J., and Blalock, J. E. (1987). An ACTH receptor on human mononuclear leukocytes. New Engl. J. Med. 317, 1266-1269.
124. Solomon, G. F. (1997). Clinical and social implications of stress-induced neuroendocrine-immune interactions. In "Stress, Stress Hormones and the Immune System" (J. C. Buckingham, G. E. Gillies, and A-M. Cowell, eds.), pp. 225-239. John Wiley and Sons, Chichester.
125. Star, R. A., Rajora, N., Huang, J., Stock, R. C, Catania, A., and Lipton, J. M. (1995). Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte-stimulating hormone. Proc. Nntl. Acad. Sci. USA 92, 8016-8020.
126. Stein, C, Hassan, A. H. S., Lehrberger, K., Giefing, J., and Yassouridis, A. (1993). Local analgesic effect of endogenous opioid peptides. Lancet 342, 321-322.
127. Stenzcl-Poore, M. P., Duncan, J. E., Rittenberg, M. B., Bakke, A. C, and Heinrichs, S. C. (1996). CRII overproduction in transgenic mice. Ann. N.Y. Acad. Set. 780, 36-48.
128. Stephanou, A., Jessop, D. S., Knight, R. A., and Lightman, S. L. (1990). Corticotropin-releasing factor-like immunoreactivity and mRNA in human leucocytes. Brain Behav. Immun. 4, 67-73.
129. Straub, R. H., Dorner, M., Riedel, J., Kubitza, M., Van Rooijcn, N., Lang, B., Scholmerich, J., and Falk, W. (1998). Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission. Am. J. Physiol. 274, R997-R1003.
130. Takeba, Y, Suzuki, N., Kancko, A., Asai, T, and Sakane, T. (2001). Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 28, 2176-2183.
131. ten Bokum, A. M., Melief, M. J., Sehonbrunn, A., Van Der Ham, F., Lindeman, J., Hotland, L. J., Lamberts, S. W., and van Hagen, P. M. (1999a). Immunohistochemical localization of somatostatin receptor sst2A in human rheumatoid synovium. J. Rheumatol. 26, 532-535.
132. ten Bokum, A. M., Lichtenauer-Kaligis, E. C, Melief, M. J., van Koetsveld. P. M., Bruns, C, van Hagen, P. M., Holland, L. J., Lamberts, S. W., and Hazenberg, M. P. (1999b). Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis. J. Endocrinol. 161, 167-175.
133. ten Bokum, A. M., Hofland, L. J., and van Hagen, P. M. (2000). Somatostatin and somatostatin receptors in the immune system: A review. Eur. Cytokine Netw. 11, 161-176.
134. Udelsman, R., Harwood, J. P., Millan, M. A., Chrousos, G. P., Goldstein, D. S., Zimlichman, R., Catt, K. J., and Aguilera, G. (1986). Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature (London) 319, 147-150.
135. Uzuki, M., Sasano, H., Muramatsu, Y, Totsune, K., Takahashi, K., Oki, Y, Lino, K., and Sawai, T. (2001). Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin. Sci. (London). 100, 577-589.
136. Vanneste, Y, Thome, A. N., Vandermissen, E., Charlet, G, Franchimont, D., Martens, H., Lliaubet, A.-M., Schimpff, R.-M., Rostene, W., and Geenen, V. (1997). Identification of ncurotensin-related peptides in human thymic epithelial cell membranes with major histocompatibility complex class 1 molecules. J. Neuroimmunol. 76, 161-166.
137. Vcnihaki, M., Dikkes, P., Carrigan, A., and Karalis, K. P. (2001). Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J. Clin. Invest. 108, 1159-1166.
138. Wang, X., Xing, L., Xing, Y, Tang, Y, and Han, C. (1999). Identification and characterization of immunoreactive calcitonin gene-related peptide from lymphocytes of the rat. J. Neuroimmunol. 94, 95-102.
139. Weigent, D. A., Blalock, J. E., and LeBoeuf, R. D. (1991). An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 128, 2053-2057.
140. Williamson, S. A., Knight, R. A., Lightman, S. L., and Hobbs, J. R. (1988). Effects of β-endorphin on specific immune responses in man. Immunology 65, 47-51.
141. Xing, L., Guo, J., and Wang, X. (2000). Induction and expression of β-calcitonin generelated peptide in rat T lymphocytes and its significance. J. Immunol. 165, 4359-4366.
142. Yin, D., Mufson, A., Wang, R., and Shi, Y (1999). Fas-mediated cell death promoted by opioids. Nature (London) 397, 218.